.jpg?#)
Biotech markets fall as industry takes stock of Marks exit at FDA
The departure of one of the FDA’s highest-profile regulators, whose career was defined by advancing new technologies to patients, rattled investors and companies who were already feeling insecure. Friday’s shock exit of ...
The departure of one of the FDA’s highest-profile regulators, whose career was defined by advancing new technologies to patients, rattled investors and companies who were already feeling insecure.
Friday’s shock exit of ...
